PCR Allelotyping of Human Ovarian Cancer
Author Information
Author(s): R.J. Osborne, V. Leech
Primary Institution: University of Cambridge School of Clinical Medicine
Hypothesis
The study aims to examine the location and frequency of allele loss throughout the genome in human epithelial ovarian tumors using microsatellite polymorphisms.
Conclusion
The study found a high frequency of allele loss in specific chromosomal regions, suggesting the presence of new tumor-suppressor genes in ovarian cancer.
Supporting Evidence
- A high frequency of allele loss was observed at several chromosomal arms, including 17p and 17q.
- The mean allele loss per tumor was found to be 28%.
- Partial loss of chromosome arms was more common than complete loss of heterozygosity for some loci.
- Only two tumors showed no evidence of deletion at any locus.
- Allelotyping was effective for analyzing very small tumor samples.
Takeaway
Researchers looked at DNA from 25 ovarian tumors to see where important genetic information was missing, which could help understand cancer better.
Methodology
The study used microsatellite polymorphisms to analyze allele loss in tumor samples and compared them to normal blood lymphocyte DNA.
Limitations
The study was limited to poorly differentiated serous stage III tumors, which may not represent all ovarian cancer types.
Participant Demographics
The study involved 25 malignant epithelial ovarian tumors, primarily of serous histology.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website